Paragon 28 Acquires Assets of Additive Orthopaedics

Paragon 28 Acquires Disior

January 12, 2022

Medical Devices

Paragon 28, Inc. has acquired Disior Oy, a Helsinki-based developer of 3D analytics and pre-operative planning software for complex foot and ankle anatomy. Paragon 28 paid $18 million at closing with up to $8 million in contingent future payments; the closing payment was funded by drawing on its existing term loan facility.

AMETEK Acquires Paragon Medical from American Securities for ~$1.9B

October 31, 2023

Medical Devices

AMETEK, Inc. has agreed to acquire Paragon Medical, a Pierceton, Indiana-based contract manufacturer of medical components and instruments, from private equity firm American Securities in an all-cash transaction valued at approximately $1.9 billion. The deal advances AMETEK’s capabilities and footprint in medical device manufacturing and is subject to customary closing conditions and regulatory approvals.

Peak Rock Capital Affiliate Acquires Paragon Healthcare, Inc.

September 15, 2020

Healthcare Services

An affiliate of Peak Rock Capital completed the acquisition of Paragon Healthcare, Inc., a provider of ambulatory and home infusion services and specialty pharmacy. Peak Rock said it will partner with Paragon's management to support geographic expansion and continued growth through organic initiatives and strategic acquisitions.

Getinge Acquires Paragonix Technologies

August 22, 2024

Medical Devices

Getinge has completed the acquisition of Paragonix Technologies, a U.S. developer of organ preservation devices and transplant logistics services, for an estimated total consideration of USD 477 million (including earn-outs). The deal will make Paragonix a wholly owned subsidiary of Getinge and is intended to expand Getinge's transplant product portfolio and bring Paragonix's technologies to new global markets.

Zimmer Biomet to Acquire Paragon 28 (HSR Waiting Period Expires)

March 11, 2025

Medical Devices

Paragon 28 announced the expiration of the HSR Act waiting period for its previously announced acquisition by Zimmer Biomet. The companies still expect to complete the proposed merger in the first half of 2025, subject to other customary closing conditions including Paragon 28 stockholder approval and additional regulatory approvals.

Elevance Health Acquires Paragon Healthcare

March 11, 2024

Healthcare Services

Elevance Health closed its acquisition of Paragon Healthcare, an infusion services and injectable therapy provider. Following the deal, Paragon Healthcare will operate as part of CarelonRx, Elevance’s pharmacy services segment, with plans to expand geographically and scale multi-site infusion services and specialty pharmacy capabilities.